Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Targeting pyroptosis with nanoparticles to alleviate neuroinflammatory for preventing secondary damage following traumatic brain injury
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
10 intermediate papers

Works of Tasha Mott being referenced

Community integration and satisfaction with functioning after intensive cognitive rehabilitation for traumatic brain injury11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the author(s) or on any organization with which the author(s) is/are associated.
2004
Rating of Medication Influences (ROMI) Scale in Schizophrenia
1994

Author Peers

Author Last Decade Papers Cites
Tasha Mott 343 186 45 332 10 711
Rodger Wood 551 196 3 228 27 811
Matthew Egan 341 144 10 92 8 584
Thomas P. Ross 228 83 9 209 23 693
Salla Koponen 375 210 5 206 11 595
Ursula Kirk 182 71 11 193 9 598
Julie A. Testa 184 77 6 174 13 655
Yehuda Ben-Yishay 518 94 176 19 768
Lawrence G. Wilson 164 260 9 150 27 696
Jack Rattok 476 137 124 13 687
Lidia Artiola i Fortuny 165 54 28 259 23 677

All Works

Loading papers...

Rankless by CCL
2026